Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma

Clinical trial NCT02816021 · COMPLETED

Trial details

NCT number: NCT02816021
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma and Other Malignant Neoplasms of Skin Metastatic Melanoma

Start date: 2017-02-14
Primary completion: 2026-03-19
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.